KalVista Pharmaceuticals (KALV) Convertible Debt (2014)
KalVista Pharmaceuticals (KALV) reported Convertible Debt of $2.1 million for Q4 2014.
KalVista Pharmaceuticals (KALV) Convertible Debt (2014) Analysis & Trends
KalVista Pharmaceuticals (KALV) has 1 years of Convertible Debt data on file, last reported at $2.1 million in Q4 2014.
- For the quarter ending Q4 2014, Convertible Debt changed N/A year-over-year to $2.1 million; the trailing twelve-month figure through Dec 2014 stood at $2.1 million (changed N/A YoY), and the FY2014 full-year result was $2.1 million, changed N/A from the prior year.
- Convertible Debt was little changed at $2.1 million in Q4 2014.
- In the past five years, Convertible Debt ranged from a high of $2.1 million in Q4 2014 to a low of $2.1 million in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | KalVista Pharmaceuticals | 1.36 Bn | 1.36 Bn | 49.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 2.13 Mn |